![The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities | Nature Reviews Clinical Oncology The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities | Nature Reviews Clinical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41571-020-0363-5/MediaObjects/41571_2020_363_Fig1_HTML.png)
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities | Nature Reviews Clinical Oncology
![Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective | Journal of Perinatology Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective | Journal of Perinatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41372-019-0469-8/MediaObjects/41372_2019_469_Fig1_HTML.png)
Issues, challenges, and the way forward in conducting clinical trials among neonates: investigators' perspective | Journal of Perinatology
![Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension - The Lancet Digital Health Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension - The Lancet Digital Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/9b562611-fa41-4053-874f-458254f2f6bd/gr1a.jpg)
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension - The Lancet Digital Health
![Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden - The Lancet Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3808cd85-676b-4471-8a13-f4cf5e6d62a0/gr1_lrg.jpg)
Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden - The Lancet
![Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group - Value in Health Challenges in Research and Health Technology Assessment of Rare Disease Technologies: Report of the ISPOR Rare Disease Special Interest Group - Value in Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/90d8e668-ec44-4c57-893c-d37d9f435c24/gr1_lrg.jpg)